Revascularization in Nonagenarian Patients With Critical Lower Limb Ischaemia
- Conditions
- Critical Limb Ischemia
- Registration Number
- NCT02517840
- Lead Sponsor
- Hospital Universitario Getafe
- Brief Summary
The rise in life expectancy implies an increased number of nonagenarian patients who need evaluation for critical lower limb ischaemia (CLI). The study goal is to evaluate whether revascularization techniques in these patients fulfill a set of security and efficacy criteria generated from surgical results in a validated historical cohort.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 53
- Patients suffering from Critical Limb Ischemia aged 90 year-old or above
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence at 30 days of major adverse cardiovascular events (MACE) 30 days after the procedure Incidence at 30 days of major adverse cardiovascular events (MACE): stroke, myocardial infarction or death by cardiovascular cause, in percentage.
Incidence at 30 days of major adverse limb events (MALE) 30 days after the procedure Incidence at 30 days of major adverse limb events (MALE): limb acute ischemia or amputation, in percentage.
Incidence at 30 days of limb major amputations (MA) 30 days after the procedure Incidence at 30 days of limb major amputations (MA), in percentage.
- Secondary Outcome Measures
Name Time Method Limb salvage (LS) 12 months after the procedure Percentage of revascularized limb which do no require major amputation at 12 months
Survival 12 months after the procedure Percentage of patients alive at 12 months
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.